Evidence map›Paper›PMID 32436591›Full record

ArticleAllergy2020

Effect of structural stability on endolysosomal degradation and T-cell reactivity of major shrimp allergen tropomyosin.

Sandip D Kamath, Sandra Scheiblhofer, Christopher M Johnson, Yoan Machado, Thomas McLean, Aya C Taki, Paul A Ramsland, Swati Iyer, Isabella Joubert, Heidi Hofer and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Frontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Sandip D KamathAustralian Institute of Tropical Health and Medicine, James Cook University, Townsville, Qld, Australia.ORCID 0000-0002-5956-8552
Sandra ScheiblhoferDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Christopher M JohnsonMRC Laboratory of Molecular Biology, Cambridge, UK.
Yoan MachadoDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0002-8251-3744
Thomas McLeanSchool of Science, RMIT University, Melbourne, Vic., Australia.ORCID 0000-0001-5223-4210
Aya C TakiFaculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Vic., Australia.ORCID 0000-0003-3489-4367
Paul A RamslandSchool of Science, RMIT University, Melbourne, Vic., Australia.ORCID 0000-0002-2107-2738
Swati IyerDepartment of Physiology, University of Melbourne, Melbourne, Vic., Australia.ORCID 0000-0002-5962-5924
Isabella JoubertDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Heidi HoferDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0003-0160-372X
Michael WallnerDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0001-6568-7892
Josef ThalhamerDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0003-2285-6400
Jennifer RollandDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Vic., Australia.
Robyn O'HehirDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Vic., Australia.ORCID 0000-0002-3489-7595
Peter BrizaDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0002-4941-6782
Fatima FerreiraDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0003-0989-2335
Richard WeissDepartment of Biosciences, University of Salzburg, Salzburg, Austria.ORCID 0000-0003-3185-7253
Andreas L LopataAustralian Institute of Tropical Health and Medicine, James Cook University, Townsville, Qld, Australia.ORCID 0000-0002-2940-9235
University of Salzburg · ATAustralian Institute of Tropical Health and Medicine · AURMIT University · AUThe Alfred Hospital · AUThe University of Melbourne · AUMRC Laboratory of Molecular Biology · GBUniversity of British Columbia · CA

Funding

Austrian Science Fund FWF P 26997Medical Research Council MC_U105184326
6 · The paper itself

Abstract

backgroundTropomyosins are highly conserved proteins, an attribute that forms the molecular basis for their IgE antibody cross-reactivity. Despite sequence similarities, their allergenicity varies greatly between ingested and inhaled invertebrate sources. In this study, we investigated the relationship between the structural stability of different tropomyosins, their endolysosomal degradation patterns, and T-cell reactivity.

methodsWe investigated the differences between four tropomyosins-the major shrimp allergen Pen m 1 and the minor allergens Der p 10 (dust mite), Bla g 7 (cockroach), and Ani s 3 (fish parasite)-in terms of IgE binding, structural stability, endolysosomal degradation and subsequent peptide generation, and T-cell cross-reactivity in a BALB/c murine model.

resultsTropomyosins displayed different melting temperatures, which did not correlate with amino acid sequence similarities. Endolysosomal degradation experiments demonstrated differential proteolytic digestion, as a function of thermal stability, generating different peptide repertoires. Pen m 1 (T

conclusionsTropomyosin T-cell cross-reactivity, unlike IgE cross-reactivity, is dependent on structural stability rather than amino acid sequence similarity. These findings contribute to our understanding of cross-sensitization among different invertebrates and design of suitable T-cell peptide-based immunotherapies for shrimp and related allergies.

Indexed as

AllergensTropomyosinAnimalsCross ReactionsImmunoglobulin EMiceT-LymphocytesAllergensImmunoglobulin ETropomyosincross-reactivityendolysosomal degradationshrimp allergyT celltropomyosin

Identifiers

PMID32436591
PMCPMC7687109
OpenAlexW3027132048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.